Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4510
Title: S-100-negative indeterminate cell histiocytosis: A case report of an 8-month-old boy
Authors: Tang, F.
Mortimore, R.
Payton, D.
Davidson, S.
Wheller, L.
Read, J.
Kong, F. W.
Pitney, L.
Issue Date: 2021
Source: 62, (SUPPL 1), 2021, p. 78
Pages: 78
Journal: Australasian Journal of Dermatology
Abstract: Introduction: Indeterminate cell histiocytosis (ICH) is a rare cutaneous neoplastic disorder, characterised typically by the presence of dendritic cells with CD1a, S-100 and CD68 positivity. The absence of Birbeck's granules differentiates it from Langerhans cell histiocytosis (LCH). We present a case of ICH with an atypical immunohistochemical profile (CD1a positive with S-100 negative) in an infant boy. Case presentation: An 8-month-old Caucasian boy presented with four-month history of multiple (20-30) erythematous papules over his forearms, thighs, trunk and scalp, with sparing of the mucosa. The lesions appeared asymptomatic and he was otherwise healthy, with constipation as his only medical condition. On examination, he had no obvious congenital abnormalities, neurologic deficits or organomegaly. His bloods tests, chest X-ray, and abdominal ultrasound were unremarkable. Two punch biopsies showed an infiltrate of histiocytoid cells throughout dermis with intervening zones of necrosis. Immunophenotype was positive for CD1a and CD43, patch weak CD68 and negative for Langerin, CD45 and s100, favouring a diagnosis of ICH over LCH. The cutaneous lesions were treated with topical corticosteroids with good effect to date, and the patient will have follow-up with the dermatology and medical oncology teams for ongoing screening for associated malignancies. Discussion: To date, there have been less than 100 cases of ICH, with even rarer reports of ICH with S-100 negativity. This case is significant as our patient is the youngest documented case of ICH in the medical literature and contributes towards enabling a greater understanding of the pathogenesis and management of this variant.L6347383472021-04-15
DOI: 10.1111/ajd.13279
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L634738347&from=exporthttp://dx.doi.org/10.1111/ajd.13279 |
Keywords: human tissue;immunohistochemistry;immunophenotyping;infant;Langerhans cell histiocytosis;major clinical study;male;malignant neoplasm;medical literature;mucosa;necrosis;neurologic disease;papule;punch biopsy;scalp;skin defect;thigh;thorax radiography;topical drug administration;trunk;ultrasound;CD68 antigencorticosteroid;endogenous compound;langerin;leukosialin;receptor type tyrosine protein phosphatase C;t6 antigen;cancer patient;Caucasian;child;conference abstract;congenital malformation;constipation;dermatology;dermis;drug therapy;epithelioid histiocyte;follow up;forearm;human;human cell
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

64
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.